You searched for metabolic diseases - Page 42 of 63

Interview 19 Aug 2022

How re-engineering antibodies can prevent allergies

…seeing in immunotherapies ushering in a new era of mobilizing immune cells to fight off diseases, such as cancers and autoimmune diseases, do you think it will be possible to…

August 19, 2022 - 9 minutesmins - By Omnia Ibrahim

News and Trends 20 Dec 2016

What Does ‘Anti-Aging Treatment’ Mean in Biotech?

…it harder to advance treatments to prevent the diseases of aging. However, new strategies for turning promising aging science into medicines are beginning to emerge” Following leaps and bounds in…

December 20, 2016 - 5 minutesmins - By Evelyn Warner

News and Trends 21 Jul 2022

Eiger receives European approval for progeria treatment

Eiger BioPharmaceuticals Inc., which focuses on the development of innovative therapies to treat and cure hepatitis delta virus and other serious diseases, has received marketing authorization from the European Commission…

July 21, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 29 Aug 2019

HiFiBiO’s €60M Series C to Fund Cancer and Autoimmune Disease Antibody Drugs

…year to fund the development of antibodies tackling autoimmune diseases. Denmark-based Genmab raised an enormous €450M ($506M) to fund antibody drugs for cancer and autoimmune diseases when it entered the…

August 29, 2019 - 2 minutesmins - By Jonathan Smith

In Depth 14 Apr 2023

mRNA vaccines: a promising future

…the forefront in drug delivery systems. Since then, the delivery of mRNA into cells has been extensively studied for the development of vaccines for infectious diseases, but it was not…

April 14, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 21 Jul 2022

ZyVersa Therapeutics and Larkspur merge to become publicly traded biopharma company

…for inflammatory diseases and VAR 200 for renal diseases,” said Daniel J. O’Connor, chairman and CEO of Larkspur. IC 100 and VAR 200 O’Connor said IC 100, an inflammasome ASC…

July 21, 2022 - 3 minutesmins - By Jim Cornall

Interview 3 Mar 2023

Interview: how has the first gene therapy for hemophilia B transformed research?

…vice president and general manager of Commercial Operations Europe at CSL Behring to find out how this therapy has transformed research in hemophilia B, and research in rare diseases at…

March 3, 2023 - 8 minutesmins - By Roohi Mariam Peter

Best in Biotech 29 Feb 2024

6 biotech companies making a difference in pediatric care

As several diseases tend to affect children at an early age, it is no surprise that there are a number of biotech companies around the world looking to find new…

February 29, 2024 - 8 minutesmins - By Willow Shah-Neville

News and Trends 20 Dec 2017

British Gene Therapy Gets a Huge £85M Boost in Series B

Orchard Therapeutics has raised a big round of financing to gene therapy options for many rare diseases for which there are no treatments. London-based Orchard Therapeutics has managed to raise…

December 20, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

Expert Advice 16 May 2024

Types of clinical trial designs: The essentials

…with rare diseases or when the expected outcome without treatment is poor. These trials can provide preliminary data on the efficacy of a treatment, but they generally offer weaker evidence…

May 16, 2024 - 14 minutesmins - By Jules Adam

Best in Biotech 11 Jun 2024

Finland: Pushing biotech forward in the land of a thousand lakes

Finland’s biotech industry is dynamic and particularly involved in areas such as precision medicine and immunotherapy. For instance, Herantis Pharma is developing advanced therapies for neurodegenerative diseases, while TILT Biotherapeutics…

June 11, 2024 - 7 minutesmins - By Jules Adam

In Depth 19 Feb 2019

How New Microbiome Diagnostic Technologies Can Save Lives

…health, while others are responsible for infections and can be instrumental in causing all sorts of diseases, including inflammatory bowel disease or type 2 diabetes. They can even affect medical…

February 19, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

How re-engineering antibodies can prevent allergies

What Does ‘Anti-Aging Treatment’ Mean in Biotech?

Eiger receives European approval for progeria treatment

HiFiBiO’s €60M Series C to Fund Cancer and Autoimmune Disease Antibody Drugs

mRNA vaccines: a promising future

ZyVersa Therapeutics and Larkspur merge to become publicly traded biopharma company

Interview: how has the first gene therapy for hemophilia B transformed research?

6 biotech companies making a difference in pediatric care

British Gene Therapy Gets a Huge £85M Boost in Series B

Types of clinical trial designs: The essentials

Finland: Pushing biotech forward in the land of a thousand lakes

How New Microbiome Diagnostic Technologies Can Save Lives

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!